HIGHFDA DRUG

DOXOrubin Hydrochloride Liposome injection, 50 mg/25 mL (2mg/mL), 25 mL single-dose vials, Sterile, Rx only, Manufactured for: Northstar Rx LLC., Memphis, TN 38141, Manufactured by: Sun...

Presence of Particulate matter: Particulate matter identified as glass.

Source-backed recall notice

No product image was available from the source feed.

Official source
FDA DRUG
Recall date
May 12, 2026
Status
ACTIVE

Quick Facts at a Glance

Recall Date
May 12, 2026
Hazard Level
HIGH
Brands
DOXORUBICIN HYDROCHLORIDE, NorthStar RxLLC
Geographic Scope
1 states

What to Do Now

Use this page like a recall checklist: verify the product first, then act on the official remedy.

Immediate steps

  1. 1Stop using the product until you confirm whether it is included in the recall.
  2. 2Compare the product label, model number, UPC, color, size, and purchase location against the identifiers below.
  3. 3Follow the official remedy from FDA - Drug Safety; save photos, receipts, labels, and correspondence before contacting the company.
  4. 4If the product could harm a child, older adult, pet, or patient, move it out of reach immediately.

Check these identifiers

Brand
DOXORUBICIN HYDROCHLORIDE, NorthStar RxLLC
Model numbers
Lot HAG2581B, expires: 05/31/2027
UPC codes
72603-103, 72603-200, 72603-103-01, 72603-200-01
Where affected
ALL

Recall Timeline

Key dates and source checks for this recall record.

  1. Recall announced

    May 12, 2026

  2. Reported by FDA DRUG

    June 17, 2026

  3. RecallRadar source check

    June 23, 2026

  4. Consumer action

    Use the official remedy and keep documentation.

Hazard Information

Presence of Particulate matter: Particulate matter identified as glass.

What You Should Do

Consumers and healthcare providers should stop using this product immediately. Contact SUN PHARMACEUTICAL INDUSTRIES INC or your healthcare provider for guidance. Notification method: E-Mail

Get instant alerts for DOXORUBICIN HYDROCHLORIDE recalls

Be the first to know. Free instant alerts to your inbox.

No spamUnsubscribe anytime

Full Description

DOXOrubin Hydrochloride Liposome injection, 50 mg/25 mL (2mg/mL), 25 mL single-dose vials, Sterile, Rx only, Manufactured for: Northstar Rx LLC., Memphis, TN 38141, Manufactured by: Sun Pharmaceutical Ind. Ltd., Halol-Baroda Highway, Halol, Gujarat, India, NDC 72603-200-01.. Generic: DOXORUBICIN HYDROCHLORIDE; Brand: DOXORUBICIN HYDROCHLORIDE. Reason: Presence of Particulate matter: Particulate matter identified as glass.. Classification: Class I. Quantity: 675 vials. Distribution: U.S. Nationwide

Safety Guide

Not sure what to do next? Our guide walks you through the process step by step.

Read: How to Get Refunds and Replacements

Want to Know First?

Get instant alerts for recalls that affect you. Free forever.

Product Classification

Product Details

Model Numbers
Lot HAG2581B
expires: 05/31/2027
UPC Codes
72603-103
72603-200
72603-103-01
+1 more
Affected States
ALL
Report Date
June 17, 2026
Source Agency
FDA - Drug Safety
Recall Status
ACTIVE